Regenerative Engineering and Translational Medicine
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.1 | Q2 | 51.9% | 0.533 | Q2 | 63.3% |
| 2024 | 1.9 | Q3 | 28.2% | 0.498 | Q3 | 62.0% |
| 2023 | 2.2 | Q3 | 40.7% | 0.487 | Q3 | 64.0% |
| 2022 | 2.6 | 46.4% | 0.458 | Q3 | 63.6% | |
| 2021 | — | 26.8% | 0.565 | Q2 | 70.9% | |
| 2020 | — | — | 0.575 | Q2 | 70.5% | |
| 2019 | — | — | 0.382 | Q3 | 59.7% | |
| 2018 | — | — | 0.405 | Q3 | 59.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2364-4141
ISSN
2364-4133
country
CHcoverage
2015-2026